A carregar...
Novel agents for chronic lymphocytic leukemia
Chronic lymphocytic leukemia (CLL) is a heterogeneous group of B-cell neoplasm. CLL is typically sensitive to a variety of cytotoxic agents, but relapse frequently occurs with conventional approaches. The treatment of CLL is evolving rapidly with the introduction of novel drugs, such as bendamustine...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3659027/ https://ncbi.nlm.nih.gov/pubmed/23680477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-6-36 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|